Januszyk K

No ORCID on file · 2 papers in corpus · active 2019

Study types

  • other 1
2019
Current pharmaceutical biotechnology ·doi:10.2174/1389201020666190619145655

BackgroundIn the course of neoplastic diseases, a reduction in SEMA3F expression is observed, which translates into an increase in the proliferative and proangiogenic potential of cells forming the tumor and the surrounding microenvironment…

other 2019
Current pharmaceutical biotechnology ·doi:10.2174/1389201020666190717092448

BACKGROUND: VEGF-A, VEGF-B, VEGFR-1 and VEGFR-2 are important proteins involved in the induction and development of a new blood vessel network through which the tumor is properly nourished and oxygenated. OBJECTIVES: The aim of the study w…